Cargando…
It’s not ‘just a tube of blood’: principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies
Immunotherapy for cancer is now a standard pillar in the armamentarium of treatments for many cancers. Immune checkpoint inhibitors, in particular, have resulted in significant therapeutic benefit and prolongation of survival in solid organ cancers, such as melanoma and lung cancer. However, the ext...
Autores principales: | Jiang, Cindy Y, Niu, Zeqi, Green, Michael D, Zhao, Lili, Raupp, Shelby, Pannecouk, Brittany, Brenner, Dean E, Nagrath, Sunitha, Ramnath, Nithya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320252/ https://www.ncbi.nlm.nih.gov/pubmed/34321277 http://dx.doi.org/10.1136/jitc-2021-003212 |
Ejemplares similares
-
Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion
por: Surbek, Daniel, et al.
Publicado: (2019) -
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs
por: Zhang, Tian, et al.
Publicado: (2023) -
Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commission
por: De Rosa, Silvia, et al.
Publicado: (2023) -
Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015) -
Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
por: Sankar, Kamya, et al.
Publicado: (2021)